PERGOLIDE IN LATE-STAGE PARKINSON DISEASE

被引：58
作者：
LANG, AE
QUINN, N
BRINCAT, S
MARSDEN, CD
PARKES, JD
机构：
[1] UNIV LONDON,INST PSYCHIAT,DEPT NEUROL,LONDON SE5 8AF,ENGLAND
[2] UNIV LONDON KINGS COLL HOSP,LONDON SE5 8RX,ENGLAND
来源：
ANNALS OF NEUROLOGY | 1982年 / 12卷 / 03期
关键词：
D O I：
10.1002/ana.410120305
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：243 / 247
页数：5
相关论文
共 13 条
[1]   BROMOCRIPTINE ASSOCIATED WITH A PERIPHERAL DOPAMINE BLOCKING-AGENT IN TREATMENT OF PARKINSONS-DISEASE [J].
AGID, Y ;
BONNET, AM ;
POLLAK, P ;
SIGNORET, JL ;
LHERMITTE, F .
LANCET, 1979, 1 (8116) :570-572
[2]  
DUVOISIN RC, 1981, NEUROLOGY, V31, P133
[3]   EFFECTS OF (8-BETA)-8-[(METHYLTHIO)METHYL]-6-PROPYLERGOLINE ON DOPAMINERGIC FUNCTION AND BRAIN DOPAMINE TURNOVER IN RATS [J].
FULLER, RW ;
CLEMENS, JA ;
KORNFELD, EC ;
SNODDY, HD ;
SMALSTIG, EB ;
BACH, NJ .
LIFE SCIENCES, 1979, 24 (04) :375-382
[4]   INTERACTION OF PERGOLIDE WITH CENTRAL DOPAMINERGIC RECEPTORS [J].
GOLDSTEIN, M ;
LIEBERMAN, A ;
LEW, JY ;
ASANO, T ;
ROSENFELD, MR ;
MAKMAN, MH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (06) :3725-3728
[5]  
Goldstein M, 1980, Adv Biochem Psychopharmacol, V23, P75
[6]  
LADURON PM, 1979, BIOCHEM PHARMACOL, V28, P2162
[7]   PHARMACOLOGIC EFFECTS IN MAN OF A POTENT, LONG-ACTING DOPAMINE RECEPTOR AGONIST [J].
LEMBERGER, L ;
CRABTREE, RE .
SCIENCE, 1979, 205 (4411) :1151-1153
[8]   TREATMENT OF ADVANCED PARKINSON DISEASE WITH PERGOLIDE [J].
LIEBERMAN, A ;
GOLDSTEIN, M ;
LEIBOWITZ, M ;
NEOPHYTIDES, A ;
KUPERSMITH, M ;
PACT, V ;
KLEINBERG, D .
NEUROLOGY, 1981, 31 (06) :675-682
[9]  
PARKES JD, 1970, LANCET, V1, P1130
[10]   BROMOCRIPTINE TREATMENT IN PARKINSONS-DISEASE [J].
PARKES, JD ;
MARSDEN, CD ;
DONALDSON, I ;
GALEADEBONO, A ;
WALTERS, J ;
KENNEDY, G ;
ASSELMAN, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1976, 39 (02) :184-193
12